Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Tournigand, Christophe, Prof, Chibaudel, Benoist, MD, Samson, Benoit, MD, Scheithauer, Werner, Prof, Vernerey, Dewi, PhD, Mésange, Paul, PhD, Lledo, Gérard, MD, Viret, Frédéric, MD, Ramée, Jean-François, MD, Tubiana-Mathieu, Nicole, Prof, Dauba, Jérôme, MD, Dupuis, Olivier, MD, Rinaldi, Yves, MD, Mabro, May, MD, Aucoin, Nathalie, MD, Latreille, Jean, MD, Bonnetain, Franck, Prof, Louvet, Christophe, Prof, Larsen, Annette K, PhD, André, Thierry, Prof, de Gramont, Aimery, Prof
Published in The lancet oncology (01.11.2015)
Published in The lancet oncology (01.11.2015)
Get full text
Journal Article